Status:
COMPLETED
Diabetes Homeless Medication Support Single Arm Treatment Development Trial
Lead Sponsor:
Hennepin Healthcare Research Institute
Collaborating Sponsors:
National Institutes of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions:
Type 2 Diabetes
Homeless Persons
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This single-arm trial of the Diabetes Homeless Medication Support intervention alone (n=15) will test the perception and feasibility of anticipated study procedures.
Detailed Description
This study is of a set of studies with an overall goal to develop and pilot test a collaborative care intervention using motivational interviewing and behavioral activation alongside education and psy...
Eligibility Criteria
Inclusion
- Age 18 yrs. or older
- English-speaking
- Homelessness by federal definition in the last 12 mo.
- Self-reported diagnosis of type 2 diabetes, later verified in medical record
- Plan to stay in local area or be reachable by phone for the next 16 weeks
- Willingness to work on medication adherence and diabetes self-care
- HbA1c \>/= 7.5%
Exclusion
- Inability to provide informed consent (e.g., presence of a legal guardian, prisoners)
- Active psychosis or intoxication precluding ability to give informed consent
- Pregnant or lactating females.
- Patients who choose to opt out of research.
Key Trial Info
Start Date :
March 24 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 24 2022
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT04678284
Start Date
March 24 2021
End Date
March 24 2022
Last Update
April 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hennepin Healthcare
Minneapolis, Minnesota, United States, 55415